Evidence map›Paper›PMID 31920335›Full record

ArticleOncoTargets and therapy2019

MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55.

Jianhua Luo, Junsu Pan, Yan Jin, Mengyuan Li, Miao Chen

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. CEP55: Implications for Immunotherapy and Survival in Hepatocellular Carcinoma.Combinatorial chemistry & high throughput screening · 2025
    Article
  6. Article
  7. Structure and Functions of HMGB3 Protein.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer.Medical oncology (Northwood, London, England) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. LncRNATranslational cancer research · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jianhua LuoRespiratory Department, Taizhou Municipal Hospital, Taizhou, Zhejiang, People's Republic of China.
Junsu PanRespiratory Department, Taizhou Municipal Hospital, Taizhou, Zhejiang, People's Republic of China.
Yan JinRespiratory Department, Taizhou Municipal Hospital, Taizhou, Zhejiang, People's Republic of China.
Mengyuan LiRespiratory Department, Taizhou Municipal Hospital, Taizhou, Zhejiang, People's Republic of China.
Miao ChenDepartment of Oncology, Tongde Hospital of Zhejiang Province, Hangzhou 310012, People's Republic of China.ORCID 0000-0002-1181-6481
Taizhou Municipal Hospital · CNTongde Hospital of Zhejiang Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to explore whether miR-195-5p can inhibit proliferation and induce apoptosis of non-small cell lung cancer (NSCLC) cells by targeting CEP55.

methodsqRT-PCR was used to measure the expression of miR-195-5p in NSCLC cells. MTT assay, colony formation assay, and flow cytometry were used to detect the role of miR-195-5p in NSCLC cells. Western blot was used to measure the protein expression of CEP55, Bax and Bcl-2 in cells. Dual-Luciferase assay was performed to verify the relationship between miR-195-5p and CEP55.

resultsThe expression of miR-195-5p was higher in human normal lung cell lines than in NSCLC cells. MiR-195-5p overexpression inhibited cell proliferation, which could block the cell cycle of A549 cell line in the G

conclusionMiR-195-5p inhibits proliferation and induces apoptosis of NSCLC cells by negatively regulating CEP55.

Indexed as

cell apoptosiscell proliferationCEP55miR-195-5pnon-small cell lung cancerNSCLC

Identifiers

PMID31920335
PMCPMC6935316
OpenAlexW2996643695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.